companydata.dkcompanydata.dk

Hadrup BioMed Holding ApS: Financial statements 2019

CVR: 38034871

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

Hadrup BioMed Holding ApS (CVR 38034871) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 50,000 and a net result of DKK 50,000 compared with DKK 0 the year before. Equity in the 2019 report amounted to DKK 90,100. The solvency ratio was 100%.

Revenue
DKK 0
Gross Profit
DKK 50,000
Profit/Loss
DKK 50,000
Equity
DKK 90,100
Total Assets
DKK 90,100

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019050K50K90K-
20180001-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

Hadrup BioMed Holding ApS: The 2018 annual report is outApr 29, 2019

Hadrup BioMed Holding ApS has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK 0.

About Hadrup BioMed Holding ApS

Hadrup BioMed Holding ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Hadrup BioMed Holding IVS. The management consists of Sine Hadrup. The company is owned by Sine Hadrup. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -28,316 and a net result of DKK 7,013 compared with DKK 190,306 the year before. Equity in the 2025 report amounted to DKK 2,565,468.

Source: annual report 2025, Danish Business Authority

Other financial years